MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immuneering (IMRX) Ownership - Who owns Immuneering?
Immuneering Corp is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
215.01M
P/E Ratio
N/A
Total Cash
26.36M
Projected Growth
N/A
Total Debt
4M
Revenue
N/A
Risk (Beta)
-0.26
Dividend Yield
N/A
Total Cash/Share
0.73
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMRX
Capitalization
215M
P/E Ratio
N/A
Risk (Beta)
-0.26
Dividend Yield
N/A
Total Cash
26.4M
Total Cash/Share
0.73
Total Debt
4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
28.9M
P/B Ratio
7.43
Cash Flow
N/A
Earnings
-1.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
36K
Current Ratio
3.70
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-63.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-106.07
Shares Held By Institutions
12.3M
Shares Outstanding - Current
36.3M
Total Liabilities
11.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
169.091
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMRX showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com